×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Equine Healthcare Market

ID: MRFR/HC/50667-HCR
200 Pages
Rahul Gotadki
February 2026

China Equine Healthcare Market Research Report: Size, Share, Trend Analysis By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others), By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others), By Activity (Sports/Racing, Recreation, Others) and By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Equine Healthcare Market Infographic
Purchase Options

China Equine Healthcare Market Summary

As per Market Research Future analysis, the China Equine Healthcare Market size was estimated at 155.63 USD Million in 2024. The Equine Healthcare market is projected to grow from 166.21 USD Million in 2025 to 320.84 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The China equine healthcare market is experiencing robust growth driven by evolving consumer preferences and technological advancements.

  • The market is witnessing a rise in preventive care as horse owners increasingly prioritize health maintenance.
  • Integration of technology in veterinary practices is enhancing service delivery and efficiency in equine healthcare.
  • Demand for specialized services is growing, particularly in the largest segment of equine veterinary care.
  • Key market drivers include increasing horse ownership and rising awareness of equine health, which are propelling market expansion.

Market Size & Forecast

2024 Market Size 155.63 (USD Million)
2035 Market Size 320.84 (USD Million)
CAGR (2025 - 2035) 6.8%

Major Players

Merck Animal Health (US), Zoetis (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Virbac (FR), Dechra Pharmaceuticals (GB), Vetoquinol (FR), Heska Corporation (US), Patterson Companies (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

China Equine Healthcare Market Trends

The China Equine Healthcare Market is experiencing notable growth, driven by increasing awareness of animal welfare and advancements in veterinary medicine. In recent years, there has been a marked shift towards preventive care, with horse owners prioritizing regular health check-ups and vaccinations. This trend reflects a broader societal change, where the health of equines is viewed as integral to their performance and well-being. Additionally, the rise of digital technologies in veterinary practices is enhancing service delivery, allowing for more efficient diagnostics and treatment plans. As a result, the equine healthcare market is becoming more accessible and responsive to the needs of horse owners. Moreover, the demand for specialized equine healthcare services is on the rise, as owners seek tailored solutions for their animals. This includes nutritional counseling, alternative therapies, and rehabilitation services. The increasing participation in equestrian sports and recreational riding further fuels this demand, as owners are more invested in the health and performance of their horses. Consequently, the equine healthcare market is evolving, with a focus on comprehensive care that addresses both physical and mental health aspects of equines. The future appears promising, with ongoing innovations likely to shape the landscape of equine healthcare in the coming years.

Rise of Preventive Care

There is a growing emphasis on preventive care within the equine healthcare market. Horse owners are increasingly recognizing the importance of regular health check-ups and vaccinations to maintain their animals' well-being. This trend indicates a shift towards proactive management of equine health, which may lead to improved outcomes and reduced long-term costs.

Integration of Technology

The integration of technology into veterinary practices is transforming the equine healthcare market. Digital tools are enhancing diagnostics and treatment processes, making them more efficient and effective. This technological advancement could potentially improve the overall quality of care provided to equines, benefiting both owners and veterinarians.

Demand for Specialized Services

There is a noticeable increase in demand for specialized services within the equine healthcare market. Owners are seeking tailored solutions, including nutritional advice and alternative therapies, to address the unique needs of their horses. This trend suggests a more holistic approach to equine health, focusing on both physical and mental well-being.

China Equine Healthcare Market Drivers

Increasing Horse Ownership

The equine healthcare market in China is experiencing growth due to a notable increase in horse ownership. As more individuals and families invest in horses for recreational and competitive purposes, the demand for healthcare services rises. This trend is particularly evident in urban areas where equestrian sports are gaining popularity. The number of registered horses in China has reportedly increased by approximately 15% over the past five years, indicating a burgeoning interest in equine activities. Consequently, this surge in horse ownership necessitates a corresponding rise in veterinary services, nutritional products, and preventive care, thereby driving the equine healthcare market. The industry is likely to see further expansion as awareness of equine health issues grows among new owners.

Growth of Equestrian Sports

The increasing popularity of equestrian sports in China is significantly contributing to the growth of the equine healthcare market. As more individuals participate in competitive riding, dressage, and show jumping, the need for specialized healthcare services becomes apparent. This trend is supported by the establishment of more equestrian clubs and training facilities across the country. The rise in competitive events has led to a greater focus on the health and performance of horses, prompting owners to invest in comprehensive healthcare solutions. Consequently, the equine healthcare market is likely to benefit from this trend, as the demand for specialized veterinary care, nutrition, and performance-enhancing products continues to grow.

Government Support and Regulation

Government initiatives aimed at promoting animal welfare and the equine industry are significantly influencing the equine healthcare market in China. Recent policies have been introduced to enhance veterinary services and ensure the health of horses, which is crucial for both recreational and competitive sectors. The Chinese government has allocated funding to improve veterinary education and training, which is expected to elevate the standards of care available. Furthermore, regulations surrounding equine health and safety are becoming more stringent, compelling owners to seek professional healthcare services. This regulatory environment not only fosters a more responsible approach to horse ownership but also stimulates growth in the equine healthcare market as compliance with these regulations becomes essential.

Rising Awareness of Equine Health

There is a growing awareness of equine health issues among horse owners in China, which is positively impacting the equine healthcare market. Educational campaigns and increased access to information about horse care have led to a more informed public. Owners are now more likely to seek veterinary services for routine check-ups, vaccinations, and specialized treatments. This shift in mindset is reflected in the rising expenditure on equine healthcare, with reports indicating that spending on veterinary services has increased by approximately 20% in recent years. As owners prioritize the health and well-being of their horses, the demand for high-quality healthcare products and services is expected to continue to rise, further propelling the equine healthcare market.

Advancements in Veterinary Technology

Technological advancements in veterinary medicine are playing a crucial role in shaping the equine healthcare market in China. Innovations such as telemedicine, advanced diagnostic tools, and minimally invasive surgical techniques are enhancing the quality of care available to horses. These technologies not only improve treatment outcomes but also make veterinary services more accessible to horse owners in remote areas. The integration of technology into equine healthcare practices is likely to attract more clients, as owners seek the best possible care for their animals. As the industry adapts to these advancements, the equine healthcare market is expected to expand, driven by the demand for cutting-edge veterinary solutions.

Market Segment Insights

By Product: Vaccines (Largest) vs. Pharmaceuticals (Fastest-Growing)

The product segment in the China equine healthcare market is characterized by a diverse range of offerings, with vaccines holding the largest market share. This segment is followed by pharmaceuticals, which are rapidly gaining traction due to the rising demand for effective treatments and preventative measures. Other segments, such as diagnostics and medicinal feed additives, also play significant roles but do not match the dominance of vaccines. The overall distribution indicates a well-established preference for vaccines among equine healthcare providers. Growth in this segment is primarily driven by advancements in veterinary medicine, increasing awareness of disease prevention, and a growing equine population. Pharmaceuticals, in particular, are seeing fast growth as owners seek innovative solutions for equine health issues. The rising trend of pet humanization among horse owners is further fueling the demand for high-quality healthcare products, paving the way for sustained growth across various product categories.

Vaccines (Dominant) vs. Pharmaceuticals (Emerging)

Vaccines remain the dominant force in the product segment, providing critical protection against various equine diseases and maintaining health within the population. Their widespread adoption among veterinarians and horse owners is driven by strong efficacy and proven track records. In contrast, pharmaceuticals are emerging as a dynamic sector with innovations that address specific health challenges in horses. This includes targeted therapies and advanced treatment options that cater to unique needs. Both vaccines and pharmaceuticals are integral to the overall health strategy for horses, yet their market paths differ significantly, with vaccines firmly established and pharmaceuticals rapidly evolving to capture the growing demand.

By Indication: Musculoskeletal Disorders (Largest) vs. Parasite Control (Fastest-Growing)

In the China equine healthcare market, Musculoskeletal Disorders account for a significant portion of the segment share, driven by the increasing incidence of injuries and age-related conditions in horses. Following closely, Parasite Control has shown a growing share due to rising awareness among horse owners regarding the need for effective prevention and treatment strategies, making this a notable area of focus within the market. Growth trends in the segment are primarily influenced by increased equine sports participation and advancements in veterinary healthcare. The rise in disposable income among horse owners is also driving expenditures on preventive care and treatments. Innovative products catering to both treatment and prevention are emerging, propelling the overall demand in the sector.

Musculoskeletal Disorders (Dominant) vs. Parasite Control (Emerging)

Musculoskeletal Disorders represent the dominant segment in the China equine healthcare market due to the high prevalence of orthopedic issues, especially among competitive and recreational horses. This segment includes a range of treatments such as anti-inflammatory medications, surgeries, and rehabilitation therapies. On the other hand, Parasite Control is gaining traction as an emerging segment, reflecting the growing recognition of the health risks posed by parasites to equine well-being. This segment includes deworming treatments and preventive care products, supported by veterinary recommendations. The dynamic nature of these segments highlights the evolving landscape in equine healthcare, where the focus is shifting towards both treatment efficacy and preventive strategies.

By Activity: Sports/Racing (Largest) vs. Recreation (Fastest-Growing)

In the China equine healthcare market, the activity segment is primarily dominated by the Sports/Racing category, which holds a sizable market share due to the large number of competitive events and investment in racehorses. This segment benefits from the increased focus on performance enhancement and healthcare needs of horses involved in these high-stakes activities. Meanwhile, the Recreation category, although smaller, is gaining traction as more individuals engage in leisure riding and equestrian activities, contributing to a more diversified market composition. Growth trends indicate a robust rise in the Recreation segment as urbanization and improved awareness of horse care ignite interest in equestrian sports among the general populace. Factors such as increased disposable income, enhanced recreational facilities, and favorable community programs bolster this segment's expansion, positioning it as the fastest-growing category in the equine healthcare market, indicating a promising future for both sports-focused and recreational activities involving horses.

Sports/Racing (Dominant) vs. Recreation (Emerging)

The Sports/Racing segment stands as the dominant force within the activity category, characterized by substantial investments in racing infrastructure and veterinary care tailored specifically for performance-oriented horses. This segment not only includes high levels of training and healthcare services but also drives considerable economic activity through events and competitions. On the other hand, the Recreation segment is emerging as a significant player, appealing to a broader audience who are increasingly interested in equestrian pursuits for leisure and lifestyle. The growth in recreation can be attributed to changing demographics, with younger generations seeking engaging activities, and an overall cultural shift towards valuing holistic animal care and equine companionship.

By Distribution Channel: Veterinary Hospitals & Clinics (Largest) vs. E-commerce (Fastest-Growing)

In the distribution channel segment of the equine healthcare market, Veterinary Hospitals & Clinics command the largest market share, showcasing their pivotal role in delivering healthcare services for horses. E-commerce, on the other hand, is rapidly gaining ground, appealing to tech-savvy consumers who prefer the convenience of online shopping for equine products and services. While both channels play crucial roles, the shift towards digital purchasing reflects changing consumer preferences. The growth trends within the distribution channel segment are significantly influenced by the increasing digitalization of the market and the rising awareness of equine health. Veterinary Hospitals & Clinics continue to benefit from their established trust and relationships with horse owners, whereas E-commerce is leveraging technological advancements to enhance customer experience and accessibility. The competition between these channels is shaping the dynamics of the China equine healthcare market, with emerging players seeking to innovate in both areas.

Veterinary Hospitals & Clinics (Dominant) vs. E-commerce (Emerging)

Veterinary Hospitals & Clinics are the dominant players in the equine healthcare distribution channel, providing a comprehensive range of services, including diagnostics, treatment, and preventive care. Their established infrastructure, including experienced veterinarians and advanced medical equipment, contributes significantly to their market position. Conversely, E-commerce represents an emerging trend, allowing consumers to access various equine healthcare products and information rapidly. This channel caters to a growing demographic that prefers convenient shopping experiences and is willing to embrace online platforms. With the COVID-19 pandemic accelerating the adoption of online services, E-commerce is poised for substantial growth, attracting both traditional veterinarians and innovative startups, enhancing competition and market responsiveness.

Get more detailed insights about China Equine Healthcare Market

Key Players and Competitive Insights

The equine healthcare market in China is characterized by a dynamic competitive landscape, driven by increasing awareness of equine health and rising investments in veterinary services. Key players such as Merck Animal Health (US), Zoetis (US), and Boehringer Ingelheim (DE) are strategically positioned to leverage innovation and expand their market presence. Merck Animal Health (US) focuses on developing advanced vaccines and therapeutics, while Zoetis (US) emphasizes digital health solutions and data analytics to enhance veterinary care. Boehringer Ingelheim (DE) is known for its commitment to research and development, particularly in equine vaccines, which collectively shapes a competitive environment that prioritizes innovation and customer-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market appears moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. This competitive structure allows for a diverse range of products and services, catering to the varying needs of equine healthcare providers and horse owners.

In October Merck Animal Health (US) announced the launch of a new equine vaccine aimed at combating a prevalent respiratory disease in horses. This strategic move is significant as it not only addresses a critical health issue but also reinforces Merck's commitment to innovation in equine health. The introduction of this vaccine is likely to enhance the company's market position and strengthen its relationships with veterinarians and horse owners alike.

In September Zoetis (US) unveiled a digital platform designed to streamline veterinary practices and improve client communication. This initiative reflects a growing trend towards digitalization in the equine healthcare sector, suggesting that Zoetis is keen on integrating technology into its service offerings. By enhancing operational efficiency and client engagement, Zoetis may solidify its competitive edge in a rapidly evolving market.

In August Boehringer Ingelheim (DE) expanded its research facilities in China, focusing on equine health solutions. This expansion indicates a long-term commitment to the region and a strategic effort to enhance its R&D capabilities. By investing in local infrastructure, Boehringer Ingelheim is likely to accelerate the development of innovative products tailored to the specific needs of the Chinese equine market.

As of November current trends in the equine healthcare market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence in veterinary practices. Strategic alliances among key players are shaping the competitive landscape, fostering collaboration that enhances product offerings and market reach. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This transition may redefine how companies engage with customers and position themselves in the market.

Key Companies in the China Equine Healthcare Market include

Industry Developments

Recent developments in the China Equine Healthcare Market have been noteworthy, particularly with companies focusing on expanding their product offerings and strengthening their market position. Neogen has been enhancing its portfolio through innovative healthcare solutions, while Zoetis has introduced advanced vaccines tailored for disease prevention in equine. In terms of mergers and acquisitions, there have been significant movements; for instance, in June 2023, Boehringer Ingelheim announced a strategic acquisition to bolster its veterinary pharmaceutical capabilities in China, a move that is expected to enhance its product distribution and local expertise. 

This aligns with the growing trend of consolidation within the market as companies look to leverage synergies. The healthcare market for equines in China is also witnessing a rise in investments driven by an increase in the population of specialized horses, reflecting a projected growth in market valuation, which is also attributed to heightened awareness of equine health. The overall impact of these developments is propelling the market forward, with major players like Elanco Animal Health and Merck Animal Health continuously adapting to meet evolving regulatory standards and consumer needs in the region.

Future Outlook

China Equine Healthcare Market Future Outlook

The Equine Healthcare Market in China is projected to grow at a 6.8% CAGR from 2025 to 2035, driven by increasing equine population, rising awareness of health, and advancements in veterinary technology.

New opportunities lie in:

  • Development of telemedicine platforms for remote veterinary consultations.
  • Expansion of specialized equine nutrition products targeting performance horses.
  • Implementation of integrated health management software for equine facilities.

By 2035, the equine healthcare market is expected to achieve substantial growth and innovation.

Market Segmentation

China Equine Healthcare Market Product Outlook

  • Vaccines
  • Pharmaceuticals
  • Medicinal Feed Additives
  • Diagnostics
  • Software & Services
  • Others

China Equine Healthcare Market Activity Outlook

  • Sports/Racing
  • Recreation
  • Others

China Equine Healthcare Market Indication Outlook

  • Musculoskeletal Disorders
  • Parasite Control
  • Internal Medicine
  • Equine Herpes Virus
  • Equine Encephalomyelitis
  • Equine Influenza
  • West Nile Virus
  • Tetanus
  • Others

China Equine Healthcare Market Distribution Channel Outlook

  • Veterinary Hospitals & Clinics
  • E-commerce
  • Others

Report Scope

MARKET SIZE 2024 155.63(USD Million)
MARKET SIZE 2025 166.21(USD Million)
MARKET SIZE 2035 320.84(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.8% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Merck Animal Health (US), Zoetis (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Virbac (FR), Dechra Pharmaceuticals (GB), Vetoquinol (FR), Heska Corporation (US), Patterson Companies (US)
Segments Covered Product, Indication, Activity, Distribution Channel
Key Market Opportunities Integration of telemedicine and digital health solutions in the equine healthcare market.
Key Market Dynamics Rising demand for advanced veterinary services drives innovation in equine healthcare solutions across the region.
Countries Covered China
Leave a Comment

FAQs

What is the projected market size of the China Equine Healthcare Market in 2024?

The China Equine Healthcare Market is expected to be valued at 155.4 million USD in 2024.

What is the anticipated market size of the China Equine Healthcare Market by 2035?

By 2035, the overall market is expected to grow significantly to a valuation of 931.8 million USD.

What is the expected compound annual growth rate (CAGR) for the China Equine Healthcare Market from 2025 to 2035?

The market is anticipated to grow at a CAGR of 17.684% from 2025 to 2035.

Which products are driving growth in the China Equine Healthcare Market?

Key products driving the market include vaccines, pharmaceuticals, medicinal feed additives, diagnostics, and software and services.

What will be the market size for vaccines in the China Equine Healthcare Market in 2035?

The market for vaccines is expected to reach 150.0 million USD by 2035.

What is the estimated market value for pharmaceuticals in the China Equine Healthcare Market in 2024?

The pharmaceuticals segment is estimated to be valued at 40.0 million USD in 2024.

Who are the key players in the China Equine Healthcare Market?

Major players include Neogen, Huvepharma, Zoetis, Merck Animal Health, and Elanco Animal Health.

How much is the diagnostics market segment valued at in 2024?

The diagnostics segment of the market is valued at 20.0 million USD in 2024.

What growth opportunities exist within the China Equine Healthcare Market?

Emerging trends such as increased pet ownership and advancements in veterinary technologies present significant growth opportunities.

What is the expected valuation of the medicinal feed additives segment in 2035?

The medicinal feed additives segment is projected to be valued at 180.0 million USD by 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions